SEC Form 4 · accession 0001193125-26-290586
Benitec Biopharma Inc. · BNTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Kevin Buchi
Director
Period of report
Jun 29, 2026
Accepted (ET)
Jun 30, 2026 · 4:20 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001808898
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 29, 2026 | G | 51,813 | $0.00 | D | 52,097 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code.